Document Type
Article
Department
Paediatrics and Child Health
Abstract
The BCG vaccine is known to impart nonspecific immunological benefits alongside conferring protection to tuberculosis in endemic regions. It is also known to protect against bladder cancer and other respiratory tract infections. During the coronavirus disease 2019 (COVID-19) pandemic, the BCG vaccine has gained attention due to its role in conferring protective immunity. We demonstrate the potential immunological protective mechanisms that play a role against COVID-19. We conduct a global assessment of the countries that have the highest and lowest mortality rates determined by an a priori methodology. Lastly, we discuss the potential limitations of incorporating BCG vaccines as potential strategies against COVID-19 and provide recommendations regarding their use in ongoing and future epidemics.
Publication (Name of Journal)
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
Recommended Citation
Sarfraz, Z.,
Sarfraz, A.,
Pandav, K.,
Makkar, S. S.,
Siddiqui, S. H.,
Patel, G.,
Platero-Portillo, T.,
Singh, B. M.,
Maideen, M. H.,
Sarvepalli, D.,
Sarfraz, M.
(2021). Variances in BCG protection against COVID-19 mortality: A global assessment. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 24.
Available at:
https://ecommons.aku.edu/pakistan_fhs_mc_women_childhealth_paediatr/1032
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-No Derivative Works 4.0 International License.
Comments
Issue, and pagination are not provided by the author/publisher